SCHEMBL19258253

SCHEMBL19258253

Cc1ccc2c(oc3ccccc32)c1N1c2nccnc2N(c2ccccc2)[C@H]1C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.35
HSD17B10 Q99714 4/20 0.35
MEN1 O00255 4/20 0.35
KMT2A Q03164 4/20 0.35
MAPT P10636 3/20 0.35
HTT P42858 3/20 0.35
MAPK1 P28482 2/20 0.35
KDM4E B2RXH2 1/20 0.35
HCRTR1 O43613 1/20 0.35
TP53 P04637 1/20 0.35
HPGD P15428 1/20 0.35
ALDH1A1 P00352 4/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
NPSR1 Q6W5P4 2/20 0.33
NPY1R P25929 1/20 0.33
NPY2R P49146 1/20 0.33
LMNA P02545 4/20 0.32
CA12 O43570 2/20 0.32
CA9 Q16790 2/20 0.32
DRD4 P21917 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19224781 1.00 TSHR (0.35) TSHRHSD17B10MEN1KMT2AMAPT
SCHEMBL19258090 1.00 TSHR (0.35) TSHRHSD17B10MEN1KMT2AMAPT
SCHEMBL21074238 0.91 TSHR (0.36) TSHRHSD17B10MEN1KMT2AMAPT
SCHEMBL19999708 0.91 TSHR (0.36) TSHRHSD17B10MEN1KMT2AMAPT
SCHEMBL20349234 0.90 TSHR (0.33) TSHRHSD17B10MEN1KMT2AMAPT
SCHEMBL21074240 0.90 TSHR (0.33) TSHRHSD17B10MEN1KMT2AMAPT
SCHEMBL20349237 0.90 TSHR (0.33) TSHRHSD17B10MEN1KMT2AMAPT
SCHEMBL21074254 0.90 TSHR (0.33) TSHRHSD17B10MEN1KMT2AMAPT
SCHEMBL19999704 0.90 TSHR (0.33) TSHRHSD17B10MEN1KMT2AMAPT
SCHEMBL19999706 0.90 TSHR (0.33) TSHRHSD17B10MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3858842-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES Universal Display Corporation (US) 2021-08-04 EP disclosed
US-10276805-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2019-04-30 US disclosed
US-20180090691-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2018-03-29 US disclosed
US-20180090691-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2018-03-29 US disclosed
EP-3205658-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES Universal Display Corporation (US) 2017-08-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180090691-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES EML4, TYR, CPNE4 TSHR 3771/4885HSD17B10 4713/4885MEN1 1904/4885
US-10276805-B2 Organic electroluminescent materials and devices EML4, TYR, CPNE4 TSHR 3771/4885HSD17B10 4713/4885MEN1 1904/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.